Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126674082 | 12667408 | 2 | F | 20160829 | 20160819 | 20160902 | PER | US-PFIZER INC-2016380243 | PFIZER | 69.00 | YR | F | Y | 0.00000 | 20160902 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126674082 | 12667408 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, UNK | Y | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | ||||||
| 126674082 | 12667408 | 2 | SS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, 1X/DAY | Y | 20699 | 75 | MG | QD | ||||||
| 126674082 | 12667408 | 3 | SS | CODEINE | CODEINE | 1 | Oral | UNK | Y | 0 | |||||||||
| 126674082 | 12667408 | 4 | C | ZYPREXA | OLANZAPINE | 1 | 2.5 MG, 1X/DAY (1QD) | 0 | 2.5 | MG | QD | ||||||||
| 126674082 | 12667408 | 5 | C | LOVASTATIN. | LOVASTATIN | 1 | 40 MG, 1X/DAY (1QD) | 0 | 40 | MG | QD | ||||||||
| 126674082 | 12667408 | 6 | C | MIRAPEX | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | 0.125 MG, 1X/DAY(1QD) | 0 | .125 | MG | QD | ||||||||
| 126674082 | 12667408 | 7 | C | DICLOFENAC | DICLOFENAC | 1 | 50 MG, AS NEEDED (1Q8 PRN ) | 0 | 50 | MG | |||||||||
| 126674082 | 12667408 | 8 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 50 MG, 1X/DAY(1QD) | 0 | 50 | MG | QD | ||||||||
| 126674082 | 12667408 | 9 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | 05 MG, UNK | 0 | 5 | MG | |||||||||
| 126674082 | 12667408 | 10 | C | ZETIA | EZETIMIBE | 1 | 10 MG, 1X/DAY (1QD) | 0 | 10 | MG | QD |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126674082 | 12667408 | Drug hypersensitivity | |
| 126674082 | 12667408 | Nausea | |
| 126674082 | 12667408 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126674082 | 12667408 | 2 | 2006 | 2008 | 0 | |
| 126674082 | 12667408 | 3 | 2006 | 2008 | 0 | |
| 126674082 | 12667408 | 10 | 20160504 | 0 |